Siheung-si, Gyeonggi-do, South Korea

Jae Heon Lee

This inventor holds 1 USPTO granted patent. Top assignees: Hanmi Fine Chemical Co., Ltd., Hanmi Pharm. Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Heon Lee. Retrieved from https://idiyas.com/inventor/jae-heon-lee-7bu0k3z1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jae Heon Lee: Innovator in Bioactive Polypeptide Conjugates

Introduction

Jae Heon Lee is a notable inventor based in Siheung-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of bioactive compounds, particularly through his innovative patent work. His expertise and dedication to research have led to advancements that benefit various industries.

Latest Patents

Jae Heon Lee holds a patent for a "Polyethylene Glycol Derivative, Composition Comprising Same, and Method for Preparing Bioactive Polypeptide Conjugate by Using Same." This patent highlights his focus on developing new methods and compositions that enhance the efficacy of bioactive polypeptides.

Career Highlights

Throughout his career, Jae Heon Lee has worked with prominent companies such as Hanmi Fine Chemical Co., Ltd. and Hanmi Pharm. Co., Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the advancement of pharmaceutical and chemical products.

Collaborations

Jae Heon Lee has collaborated with Yeon Jeong Jang, further enhancing his research and development efforts. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in their projects.

Conclusion

Jae Heon Lee's contributions to the field of bioactive polypeptide conjugates demonstrate his commitment to innovation and research. His patent and collaborations reflect his significant impact on the industry, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…